Summary & Overview

Other Digestive System Diagnoses with MCC: Inpatient Reimbursement Overview

DRG 393 encompasses other digestive system diagnoses with a Major Complication or Comorbidity, capturing higher-severity inpatient cases that drive greater resource use. Classification into this Diagnosis-Related Group influences Medicare inpatient reimbursement under the Centers for Medicare & Medicaid Services inpatient prospective payment system.

Other Digestive System Diagnoses with MCCDRG Other Digestive System Diagnoses with MCCDRG 393Diagnosis-Related GroupInpatient ReimbursementMedicareGastroenterologyGeneral SurgeryHospital Coding

DRG 393 Overview

DRG 393 covers inpatient hospital stays for other diagnoses of the digestive system when a Major Complication or Comorbidity is present, representing more medically complex cases than the non-Major Complication or Comorbidity variants. This Diagnosis-Related Group groups patients with higher resource use due to the severity of illness, comorbid conditions, or complications requiring additional management. It matters for Medicare payment because classification into this Diagnosis-Related Group affects relative payment weight and reimbursement under the inpatient prospective payment system administered by the Centers for Medicare & Medicaid Services. Accurate clinical coding and documentation determine assignment to this Diagnosis-Related Group and the associated payment level.

Clinical Trials

Acute intervention trials evaluating endoscopic or surgical techniques for complicated digestive conditions (for example studies comparing minimally invasive endoscopic hemostasis versus operative control for severe GI bleeding, or novel stent/closure strategies for perforations). These studies enroll hospitalized patients with acute, often life-threatening digestive system diagnoses with major complications or comorbidities, focusing on short-term efficacy, complication rates, and time to clinical stabilization. Results inform clinicians on best practices for urgent care and help payers understand resource use drivers such as procedure intensity, ICU needs, and readmission risk.
Comparative effectiveness and management strategy studies in medically complex inpatients, assessing alternative diagnostic pathways, pharmacologic regimens, or bundled care protocols for conditions like severe pancreatitis, complicated biliary disease, or ischemic/inflammatory bowel presentations. These trials typically include patients with multiple comorbidities and major complications (the MCC population), comparing outcomes such as length of stay, complication incidence, and need for escalation to surgery. Findings are directly relevant to hospital groups and payers because they can identify approaches that reduce high-cost events, standardize care for complex cases, and improve resource allocation.
Post-discharge and transitional care outcomes research examining readmission prevention, rehabilitation needs, and long-term functional or nutritional recovery among patients discharged after major digestive-system hospitalizations with complications. Such cohort or interventional studies follow patients after discharge to evaluate interventions like coordinated outpatient follow-up, nutritional support programs, or home-based monitoring to reduce rehospitalization and late complications. This area matters to providers and payers by targeting downstream costs and quality metrics tied to this DRG, informing policies that balance inpatient investment with outpatient support to improve overall outcomes.

Related Codes

369-MAJOR-ESOPHAGEAL-DISORDERS-WITH-CC

Major Esophageal Disorders with CC: Inpatient Reimbursement Overview

391-ESOPHAGITIS-GASTROENTERITIS-AND-MISCELLANEOUS-DIGESTIVE-DISORDERS-WITH-MCC

Esophagitis, Gastroenteritis and Miscellaneous Digestive Disorders with MCC: Inpatient Reimbursement Overview

390-GASTROINTESTINAL-OBSTRUCTION-WITHOUT-CC-MCC

Gastrointestinal Obstruction without CC/MCC: Inpatient Reimbursement Overview

351-INGUINAL-AND-FEMORAL-HERNIA-PROCEDURES-WITH-CC

Inguinal and Femoral Hernia Procedures with CC: Inpatient Reimbursement Overview

333-RECTAL-RESECTION-WITH-CC

Rectal Resection with CC: Inpatient Reimbursement Overview

372-MAJOR-GASTROINTESTINAL-DISORDERS-AND-PERITONEAL-INFECTIONS-WITH-CC

Major Gastrointestinal Disorders and Peritoneal Infections with CC: Inpatient Reimbursement Overview

368-MAJOR-ESOPHAGEAL-DISORDERS-WITH-MCC

Major Esophageal Disorders with MCC: Inpatient Reimbursement Overview

337-PERITONEAL-ADHESIOLYSIS-WITHOUT-CC-MCC

Peritoneal Adhesiolysis without CC/MCC: Inpatient Reimbursement Overview

395-OTHER-DIGESTIVE-SYSTEM-DIAGNOSES-WITHOUT-CC-MCC

Other Digestive System Diagnoses without CC/MCC: Inpatient Reimbursement Overview

373-MAJOR-GASTROINTESTINAL-DISORDERS-AND-PERITONEAL-INFECTIONS-WITHOUT-CC-MCC

Major Gastrointestinal Disorders and Peritoneal Infections without CC/MCC: Inpatient Reimbursement Overview

Showing 1–10 of 57

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.